Patient on bisphosphonates sues dentist after implant failure

Miscommunication leads to legal action over dental implant complications in bisphosphonate user

Close-up 3D rendering of dental implants embedded in a transparent jaw model, highlighting the integration of artificial teeth with the bone.
Caption: A digital rendering of dental implants in a transparent jaw model, illustrating the precision and complexity of implant placement—a crucial consideration for patients on bisphosphonate therapy. Image Courtesy of The Dental Implant Place

A recent legal case underscores the critical importance of thorough patient evaluation and clear communication in dental practice, especially concerning patients on bisphosphonate therapy. A patient undergoing bisphosphonate treatment experienced dental implant failure, leading to a lawsuit against the attending dentist.

Understanding Bisphosphonates and Their Dental Implications

Bisphosphonates are commonly prescribed to manage osteoporosis and other bone-related conditions by inhibiting bone resorption. However, these medications have been associated with osteonecrosis of the jaw (ONJ), a severe condition where jawbone tissue fails to heal after injury, leading to bone exposure and necrosis. Dental procedures, particularly those involving bone manipulation like implants, can exacerbate this risk.

The Case at Hand

In this instance, a patient receiving bisphosphonate therapy underwent a dental implant procedure. Due to a miscommunication, the dentist was unaware of the patient's medication history. Subsequently, the implant failed, and the patient developed complications consistent with ONJ. Alleging negligence, the patient filed a lawsuit against the dentist.

Legal Precedents

This case is not isolated. In 2009, a Montana jury awarded $3.2 million to a woman who developed ONJ after using the bisphosphonate drug Zometa. The lawsuit claimed that the manufacturer failed to disclose dental health risks associated with the drug. Similarly, in 2010, Merck was ordered to pay $8 million in compensatory damages to a woman who developed ONJ after taking Fosamax, another bisphosphonate medication.

Lessons for Dental Professionals

This case highlights the necessity for dentists to:

  • Conduct Comprehensive Medical Histories: Ensure all medications, especially bisphosphonates, are documented before planning surgical procedures.
  • Maintain Open Communication: Engage in detailed discussions with patients about their medical history and potential risks associated with dental treatments.
  • Collaborate with Healthcare Providers: Coordinate with the patient's primary care physician or specialist to assess the suitability of dental implants or other invasive procedures.
  • Stay Informed: Keep abreast of current research linking medications like bisphosphonates to dental complications.

Conclusion

Ensuring patient safety requires diligent medical history assessments and clear communication. Awareness of medications such as bisphosphonates and their potential impact on dental procedures is vital to prevent adverse outcomes and legal repercussions.